Active Pharmaceutical Ingredients Market Research Report - Forecast to 2023 Global Industry Survey, Growth, Competitive Landscape and Forecasts to 2023
CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)
Active Pharmaceutical Ingredients Market Research Report - Forecast to 2023
Research Across Sectors to Give Impetus to Global Active Pharmaceutical Ingredients Market 2023 • The Global Active Pharmaceutical Ingredients Market Size is expected to exhibit a strong 4.96% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The report studies the global active pharmaceutical ingredients market in detail to understand the market’s historical growth trajectory and furthermore makes projections about the market’s likely growth trajectory over the forecast period from 2018 to 2023. Key drivers and restraints affecting the global active pharmaceutical ingredients market are profiled in detail in the report. • Active pharmaceutical ingredients (APIs) are the core of any pharmaceutical formulation and comprise the part of the formulation that actually tackles the respective disease. As a result, active pharmaceutical ingredients are among the most valued and studied components of the pharmaceutical sector and are researched extensively in order to bring about steady drug development in various fields. The growing prevalence of various major diseases has led to a growing demand for new active pharmaceutical ingredients, which is likely to be a major driver for the global active pharmaceutical ingredients market. Capacity expansion as well as research and development into the development of new APIs are likely to be promising avenues for major players in the active pharmaceutical ingredients market over the forecast period. The increasing importance of generics across the healthcare sector is also likely to be a major driver for the active pharmaceutical ingredients market over the forecast period.
2
www.marketresearchfuture.com
Active Pharmaceutical Ingredients Market Research Report - Forecast to 2023 Segmentation: • The global active pharmaceutical ingredients market is segmented on the basis of manufacturing process, type of synthesis, API formulation, application, molecule type, and region. • By manufacturing process, the global active pharmaceutical ingredients market is bifurcated into captive and contract manufacturing. • By type of synthesis, the global active pharmaceutical ingredients market is segmented into synthetic and biotech. The biotech synthesis segment is further sub-segmented into monoclonal antibodies, recombinant proteins, vaccines, and others. • By API formulation, the global active pharmaceutical ingredients market is segmented into generic and branded/innovative. • By application, the global active pharmaceutical ingredients market is segmented into cardiovascular diseases, oncology, neurological disorders, orthopedic disorders, respiratory disorders, gastrointestinal disorders, urology, and others. The cardiovascular disease segment holds the largest share in the global active pharmaceutical ingredients market and is likely to remain the leading revenue generator over the forecast period due to the growing demand for effective cardiovascular drug formulations. The growing prevalence of cardiovascular diseases in developed regions is also likely to be a major driver for the segment over the forecast period. • Based on molecule type, the global active pharmaceutical ingredients market is segmented into small molecule and large molecule.
3
www.marketresearchfuture.com
Active Pharmaceutical Ingredients Market Research Report - Forecast to 2023 Application & Major Players in this Research: Active Pharmaceutical Ingredients Market Prominent Players: • Leading players in the global active pharmaceutical ingredients market include Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Novartis AG, GSK plc, Boehringer Ingelheim GmbH, Merck & Co. Inc., Bayer AG, Abbott, Pfizer Inc., F. Hoffman-La Roche Ltd., and Sanofi SA. • In October 2019, Novartis announced plans to outsource API supply from its Ringaskiddy campus in Ireland, cutting 320 jobs in the process. • In September 2016, Pfizer Inc. completed the acquisition of Medivation Inc., expanding its capacity in the antiinfective segment. • In June 2015, Merck and Moderna announced a strategic collaboration to develop novel mRNA-based cancer vaccines for treating a number of cancers.
Get Discount @ https://www.marketresearchfuture.com/check-discount/1385
4
www.marketresearchfuture.com
Active Pharmaceutical Ingredients Market Research Report - Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), ContinuousFeed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright Š 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future.
5
www.marketresearchfuture.com
THANK YOU
MARKET RESEARCH FUTURE
salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
6
www.marketresearchfuture.com